SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:7919fa8b-bb3a-4d0a-b1e4-86559aa784b0"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:7919fa8b-bb3a-4d0a-b1e4-86559aa784b0" > Power-assisted Lipo...

  • Bloom, Joshua ATufts Medical Center (författare)

Power-assisted Liposuction for Lymphedema : A Cost-utility Analysis

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • 2022

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:7919fa8b-bb3a-4d0a-b1e4-86559aa784b0
  • https://lup.lub.lu.se/record/7919fa8b-bb3a-4d0a-b1e4-86559aa784b0URI
  • https://doi.org/10.1097/GOX.0000000000004671DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • UNLABELLED: Lymphedema is a chronic, debilitating disease that has been described as the largest breast cancer survivorship burden. Debulking surgery has been shown to improve extremity volume, improve patient quality of life, and decrease the incidence of cellulitis in the literature. This procedure is routinely covered in numerous other developed countries, yet it is still inconsistently covered in the United States.METHODS: Extremity volumes from all patients who underwent debulking surgery of the upper extremity at two institutions between December 2017 and January 2020 with at least 12 months follow-up were included. Procedural costs were calculated using Medicare reimbursement data. Average utility scores were obtained for each health state using a visual analog scale, then converted to quality-adjusted life years. A decision tree was generated, and incremental cost-utility ratios were calculated. Sensitivity analyses were performed to evaluate our findings.RESULTS: Debulking surgery is associated with a higher clinical effectiveness (quality-adjusted life year) of 27.05 compared to conservative management (23.34), with a relative cost reduction of $74,487. Rollback analysis favored debulking surgery as the cost-effective option compared to conservative management. The resulting negative incremental cost-utility ratio of -20,115.07 favored debulking surgery and indicated a dominant strategy.CONCLUSION: Our study supports the use of debulking surgery for the treatment of chronic lymphedema of the upper extremity.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Granoff, MelisaBeth Israel Deaconess Medical Center (författare)
  • Karlsson, TobiasLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Skåne University Hospital(Swepub:lu)to1487ka (författare)
  • Greene, Arin KBoston Children's Hospital (författare)
  • Brorson, HåkanLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Surgery,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital(Swepub:lu)plas-hbr (författare)
  • Chatterjee, AbhishekTufts Medical Center (författare)
  • Singhal, DhruvBeth Israel Deaconess Medical Center (författare)
  • Tufts Medical CenterBeth Israel Deaconess Medical Center (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Plastic and reconstructive surgery. Global open10:112169-7574

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy